Keating Financial Advisory Services’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1K Sell
679
-115
-14% -$4.74K ﹤0.01% 799
2025
Q4
$32.7K Buy
+794
New +$31.4K ﹤0.01% 773

Other funds holding BME

Keating Financial Advisory Services's BME Position: Q1 2026 in Review

Keating Financial Advisory Services reduced its BlackRock Health Sciences Trust (BME) stake by 14% in Q1 2026, selling an estimated $4.74K and leaving 679 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Keating Financial Advisory Services first reported a position in BME in Q4 2025 and has held it in 2 quarters since. The position peaked at $32.7K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Keating Financial Advisory Services held 679 shares of BlackRock Health Sciences Trust worth $26.1K as of Q1 2026.
  • Keating Financial Advisory Services sold 115 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $4.74K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #799 holding.
  • Keating Financial Advisory Services first reported a position in BlackRock Health Sciences Trust in Q4 2025 and has held it in 2 quarters since.
  • Keating Financial Advisory Services's BlackRock Health Sciences Trust position peaked at $32.7K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.